Blood and ultrafiltrate dosage of citrate as a useful and routine tool during continuous venovenous haemodiafiltration in septic shock patients

Nephrology Dialysis Transplantation

Volumn 26, Issue 12, 2011, Pages 3882-3888

  Mariano, Filippo ^a   Morselli, Maurizio ^a   Bergamo, Daniela ^a   Hollo, Zsuzsanna ^a   Scella, Sandro ^a   Maio, Mariella ^b   Tetta, Ciro ^c   Dellavalle, Ambrogio ^a   Stella, Maurizio ^a   Triolo, Giorgio ^a  

^a CTO HOSPITAL   (Italy)

^b Sant'Anna Hospital   (Italy)

^c Fresenius Medical Care   (Germany)

Author keywords

continuous venovenous haemodiafiltration; regional citrate anticoagulation; septic shock; systemic citratemia; ultrafiltration volume

Indexed keywords

CALCIUM; CITRIC ACID;

ADULT; AGED; ANTICOAGULATION; ARTICLE; AUTOMATION; BLOOD FLOW VELOCITY; BLOOD LEVEL; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; CONTINUOUS HEMODIAFILTRATION; CONTROLLED STUDY; COST BENEFIT ANALYSIS; CRITICALLY ILL PATIENT; EX VIVO STUDY; FEMALE; HEALTH CARE COST; HUMAN; IN VITRO STUDY; LIVER DYSFUNCTION; MALE; PRIORITY JOURNAL; RENAL REPLACEMENT THERAPY; SEPTIC SHOCK;

ADULT; AGED; AGED, 80 AND OVER; CITRIC ACID; FEMALE; HEMODIAFILTRATION; HEMODIALYSIS SOLUTIONS; HUMANS; MALE; MIDDLE AGED; SHOCK, SEPTIC; VEINS;

EID: 82255194352     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfr106     Document Type: Article

References (24)

1. Oudemans-van Straaten HM, Bosman RJ, Koopmans M et al. Citrate anticoagulation for continuous venovenous hemofiltration. Crit Care Med 2009; 37: 545-552
2. Tolwani AJ, Prendergast MB, Speer RR et al. A practical citrate anticoagulation continuous venovenous hemodiafiltration protocol for metabolic control and high solute clearance. Clin J Am Soc Nephrol 2006; 1: 79-87
3. Morgera S, Schneider M, Slowinski T et al. A safe citrate anticoagulation protocol with variable treatment efficacy and excellent control of the acid-base status. Crit Care Med 2009; 37: 2018-2024
4. Mariano F, Tedeschi L, Morselli M et al. Normal citratemia and metabolic tolerance of citrate anticoagulation for hemodiafiltration in severe septic shock burn patients. Intensive Care Med 2010; 36: 1735-1743
5. Krebs HA. Rate control of the tricarboxylic acid cycle. Adv Enzyme Regul 1970; 8: 335-353
6. Kramer L, Bauer E, Joukhadar C et al. Citrate pharmacokinetics and metabolism in cirrhotic and noncirrhotic critically ill patients. Crit Care Med 2003; 31: 2450-2455 (Pubitemid 37281728)
7. Mariano F, Tetta C, Stella M et al. Regional citrate anticoagulation in critically ill patients treated with plasma filtration and adsorption. Blood Purif 2004; 22: 313-319 (Pubitemid 39177738)
8. Morgera S, Scholle C, Voss G et al. Metabolic complications during regional citrate anticoagulation in continuous venovenous hemodialysis: single-center experience. Nephron Clin Pract 2004; 97: c131-c136 (Pubitemid 39179245)
9. Nowak MA, Campbell TE. Profound hypercalcemia in continuous veno-venous hemofiltration dialysis with trisodium citrate anticoagulation and hepatic failure. Clin Chem 1997; 43: 412-413 (Pubitemid 27066518)
10. Meier-Kriesche HU, Gitomer J, Finkel K et al. Increased total to ionized calcium ratio during continuous venovenous hemodialysis with regional citrate anticoagulation. Crit Care Med 2001; 29: 748-752 (Pubitemid 32299711)
11. Mariano F, Tetta C, Ronco C et al. Is there a real alternative anticoagulant to heparin in continuous treatments? Expert Rev Med Devices 2006; 3: 5-8
12. Chadha V, Garg U, Warady BA et al. Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 2002; 17: 819-824 (Pubitemid 36097371)
13. Hetzel GR, Taskaya G, Sucker C et al. Citrate plasma levels in patients under regional anticoagulation in continuous venovenous hemofiltration. Am J Kidney Dis 2006; 48: 806-811 (Pubitemid 44740041)
14. Bakker AJ, Boerma EC, Keidel H et al. Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Clin Chem Lab Med 2006; 44: 962-966 (Pubitemid 44155864)
15. McWhinney BC, Cowley DM, Chalmers AM. An automated method for measuring plasma citrate without protein precipitation. Clin Chem 1985; 31: 1578-1579
16. Whitfield LR, Levy G. Permeability of human and rat red blood cells to citrate. Thromb Res 1981; 21: 681-684 (Pubitemid 11117861)
17. Dellinger RP, Levy MM, Carlet JM et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med 2008; 34: 17-60
18. Mariano F, Cantaluppi V, Stella M et al. Circulating plasma factors induce tubular and glomerular alterations in septic burns patients. Crit Care 2008; 12: R42
19. Slomp J, Van der Voort PH, Gerritsen RT et al. Albumin-adjusted calcium is not suitable for diagnosis of hyper-and hypocalcemia in the critically ill. Crit Care Med 2003; 31: 1389-1393 (Pubitemid 36583848)
20. Diaz J, Acosta F, Parrilla P et al. Correlation among ionized calcium, citrate, and total calcium levels during hepatic transplantation. Clin Biochem 1995; 28: 315-317
21. Brunet S, Leblanc M, Geadah D et al. Diffusive and convective solute clearances during continuous renal replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999; 34: 486-492 (Pubitemid 29413621)
22. Flanigan MJ, Pillsbury L, Sadewasser G et al. Regional hemodialysis anticoagulation: hypertonic tri-sodium citrate or anticoagulant citrate dextrose-A. Am J Kidney Dis 1996; 27: 519-524 (Pubitemid 26111052)
23. Kreuzer M, Bonzel KE, Büscher R et al. Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding. Nephrol Dial Transplant 2010; 25: 3337-3342
24. Kozik-Jaromin J, Nier V, Heemann U et al. Citrate pharmacokinetics and calcium levels during high-flux dialysis with regional citrate anticoagulation. Nephrol Dial Transplant 2009; 24: 2244-2251